Rickettsial disease

Rickettsial disease is a bacterial infection associated with organisms in the genus Rickettsia ^[1]. The sources characterize rickettsioses as a diverse group of infections transmitted by arthropods, including tick-borne disease caused by Rickettsia conorii in Mediterranean spotted fever ^[1][3]. The available material also identifies the broader category as intracellular small Gram-negative bacteria ^[2].

The sources describe a typical systemic presentation of acute fever, headache, and skin rash, and in one review a triad of high fever, headache, and skin rash is noted ^[2][1]. Other reported symptoms include malaise, myalgia, and headache, with an inoculation eschar described as strongly suggestive when present, although it is often absent ^[1]. Severe, life-threatening complications can occur, but source-backed detail is not yet available on a unified complication pattern across all rickettsial diseases ^[2][3]. Ocular involvement is reported in the literature cited by one source, with retinitis, retinal vasculitis, and neuroretinitis described as typical findings in rickettsial infection-related uveitis ^[2].

The sources indicate worldwide distribution, with particular recognition in tropical areas and among travelers returning from endemic regions ^[1][2]. Rickettsial disease is described as an increasingly recognized cause of acute febrile illness, and one source notes that it may be clinically difficult to distinguish from other febrile illnesses ^[1][2]. Mediterranean spotted fever is identified as a tick-borne rickettsial disease due to Rickettsia conorii, and the literature notes evolving ecologic and epidemiologic understanding as well as concern about severe forms ^[3]. Rocky Mountain spotted fever is described as the most common rickettsial disease in the United States, with an overall mortality rate of 5 to 10 percent in the cited source ^[4].

Transmission is described as arthropod-borne, including infection acquired by the bite of contaminated arthropods such as ticks ^[1][2]. One source specifically characterizes Mediterranean spotted fever as tick-borne ^[3]. Source-backed detail is not yet available on person-to-person transmission or on the persistence of the organism in specific animal reservoirs for the broader disease group ^[3].

The sources specifically mention travelers and inhabitants of tropical areas as groups in whom rickettsioses are increasingly recognized ^[1]. A history of tick bite or exposure is highlighted in the context of Rocky Mountain spotted fever, and acute illness after travel from an endemic area is a key contextual clue ^[4][1]. Source-backed detail is not yet available on additional demographic or occupational risk groups for the broader disease category.

The source material emphasizes prevention as the mainstay of infection control, but does not provide a detailed prevention schedule or specific protective measures ^[2]. Because arthropod transmission is central, exposure avoidance to contaminated arthropods is the only directly supported control principle in the provided sources ^[1][2]. Early clinical suspicion is also highlighted as important for limiting morbidity, since treatment is recommended when the diagnosis is suspected on clinical grounds rather than waiting for serologic confirmation ^[1][2].

In surveillance and case recognition, rickettsial disease should be considered in a patient with acute febrile illness developing within less than 3 weeks after leaving an endemic area ^[1]. The combination of fever, headache, and rash, especially with a history of tick bite or other arthropod exposure, is a recurring signal in the sources ^[1][4][2]. Because antibodies may appear late and clinical differentiation from other febrile illnesses can be difficult, source-backed monitoring should treat the syndrome as an exposure-linked febrile rash illness rather than rely on delayed laboratory confirmation alone ^[1][2].

1. 1 Goorhuis A et al. [Rickettsioses]. Ned Tijdschr Geneeskd. 2014. PMID: 24988165. PubMed: https://pubmed.ncbi.nlm.nih.gov/24988165/
2. 2 Rickettsial disease. Saudi Journal of Ophthalmology. 2022. doi: 10.4103/sjopt.sjopt_86_22. DOI: https://doi.org/10.4103/sjopt.sjopt_86_22
3. 3 Rovery C et al. Mediterranean spotted fever. Infect Dis Clin North Am. 2008 Sep. PMID: 18755388. doi: 10.1016/j.idc.2008.03.003. PubMed: https://pubmed.ncbi.nlm.nih.gov/18755388/
4. 4 Usatine RP et al. Dermatologic emergencies. Am Fam Physician. 2010 Oct 1. PMID: 20879700. PubMed: https://pubmed.ncbi.nlm.nih.gov/20879700/
5. 5 Rickettsial disease. International Neurology. 2016. doi: 10.1002/9781118777329.ch77. DOI: https://doi.org/10.1002/9781118777329.ch77
6. 6 Rickettsial Disease. Harper's Textbook of Pediatric Dermatology. 2019. doi: 10.1002/9781119142812.ch43. DOI: https://doi.org/10.1002/9781119142812.ch43

ICD-10

A79

ICD-11

1C30

Total cases

48

Peak month

2022-06

Coverage

1 reporting countries · 2016-01-01 → 2026-05-01